Research, Science & development

Unlike most forms of dementia, which typically worsen gradually over many years, RPD progresses at an alarming pace and can lead to severe disability or death within one to two years.

The findings come from a mathematical modeling study published in Science Advances, which offers the first population-level estimates of how an HSV-1 vaccine could reshape disease trends.

Alzheimer’s disease is characterized by the accumulation of tau protein in the brain, which gradually damages nerve cells and impairs memory and cognitive function.

Researchers tested the therapy through the MATCH clinical trial, which involved 50 patients with advanced liver cirrhosis.

Insulet received Investigational Device Exemption approval from the U.S. Food and Drug Administration in March 2026, clearing the way for the trial to begin.

The study found that resistance to commonly prescribed antibiotics, including ampicillin and cotrimoxazole, now exceeds 90% in some wound infection cases.

The study suggests that tracking sleep patterns before rehabilitation begins could help healthcare teams identify patients who may need extra support to stay engaged throughout treatment.

The study showed that oral semaglutide achieved a significantly greater reduction in HbA1c levels, a key marker of blood sugar control, compared to placebo.

The summit convenes senior executives from healthcare, biotechnology, artificial intelligence, academia, and investment firms under the theme “Healthtech Frontiers: Building the Health Ecosystem of Tomorrow.”

Less than 10% of participants in the Nuvaxovid group experienced severe side effects that interfered with daily activities compared with 20% in the mNexspike group.